Sr. Global Medical Director
Alexion, AstraZeneca Rare Disease
Julia Catini, PharmD, MBA is a Senior Global Medical Director at Alexion, AstraZeneca Rare Disease. Julia is the Global Medical Amyloidosis Franchise Lead supporting clinical programs and commercialization across ATTR and light chain amyloidosis. Julia has been at AstraZeneca since 2005 and prior to AstraZeneca has held roles including Pharmacy Clinical Coordinator at Mercy Fitzgerald Hospital and Pharmacy Manager at Option Care Home Infusion in Philadelphia. She holds a PharmD from the Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, now part of St. Joseph's University in Philadelphia and a MBA in Pharmaceutical Marketing from St. Joseph's University in Philadelphia.